Page last updated: 2024-11-03

primaquine and Cerebrovascular Disorders

primaquine has been researched along with Cerebrovascular Disorders in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, GJ1
Knight, V1
Coatney, GR1
Lawless, DK1

Other Studies

1 other study available for primaquine and Cerebrovascular Disorders

ArticleYear
Vivax malaria complicated by aphasia and hemiparesis.
    Archives of internal medicine, 1963, Volume: 112, Issue:6

    Topics: Adult; Aphasia; Body Temperature; Cerebrovascular Disorders; Chloroquine; Hematocrit; Hemiplegia; Hu

1963